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Purpose: To investigate the rate and the degree of the ocular hypertensive response to dexamethasone 
ointment in children undergoing eyelid surgery. 
Methods: Dexamethasone ointment (Dexcosil
Ⓡ) was applied three times a day for the first week and twice 
a day for the second to third week postoperatively to children undergoing epiblepharon surgery. Intraocular 
pressure (IOP) was measured on the day before surgery, postoperative day 1, 7, 14, 21, 28 and 2 weeks 
thereafter until the IOP reached preoperative levels. Peak IOP, IOP net increase and time to reach a peak 
IOP were analyzed. Dexamethasone ointment was discontinued if the IOP was 25 mmHg or more.
Results: A total of 96 children (mean age, 6.5±2.7 years) were included. Preoperative mean IOP was 13.6 
±2.9 mmHg (range 7-19). After dexamethasone ointment treatment, the children showed a significant rise 
in IOP as compared with the preoperative values. The peak IOP was 20.6±4.9 mmHg (range 11-39) and 
the time to reach peak IOP was 8.5±5.9 days. The low responders (delta IOP ≤5 mmHg) of our group 
comprised 35.4% (34/96) of patients, intermediate responders (delta IOP 6-15 mmHg) comprised 56.3% 
(54/96) of patients and high responders (delta IOP≥16) comprised 8.3% (8/96) of patients. A net increase 
in IOP was significantly higher in children 5 years old or less as compared with those older than 5 years 
(age  ≤5, 9.4±7.5 mmHg vs age >5, 6.3±4.4 mmHg; p=0.015, unpaired t-test).
Conclusions: Ocular hypertensive response after dexamethasone ointment to the eyelids occurred frequently 
in children, especially those 5 years old or younger.  Korean Journal of Ophthalmology 20(3):166-170, 2006
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Epiblepharon is a frequently encountered congenital lid 
anomaly in Asian infants and children. It is a fold of skin, 
which overlaps the eyelid margin and pushes the lashes 
against the cornea. Because it causes epiphora and ocular 
irritation symptoms in some children, it needs to be corrected 
surgically. To correct epiblepharon, the redundant skin and 
abundant orbicularis muscle are excised and an adhesion 
between the subcutaneous tissue of the upper skin flap and 
the tarsal plate is made.
1 
An absorbable suture is preferred in closing the skin 
wound because most children can not tolerate suture removal. 
In most cases, the surgical wound heals without sequale, but 
sometimes the surgical wound tends to be inflamed and 
results in a hypertropic scar in relation with suture absorp-
tion. Especially in patients with allergic dermatitis, such an 
inflammatory phase can be severe and the use of steroid 
ointment may be recommended as a prevention.
Corticosteroids administered as eyedrops, ointment, or 
used systemically are indispensable in treating inflammatory 
eye diseases.
2-4 In addition as postoperative management, 
topical corticosteroids are commonly used. It prevents or 
suppresses the undesirable consequences of postoperative 
ocular inflammation including redness, swelling and tender-
ness. It is well established that prolonged use of topical 
ophthalmic corticosteroids can produce ocular hypertension 
and secondary open-angle glaucoma in susceptible indi-
viduals.
5-8 However, in children the ocular hypertensive 
response is not well documented. 
We examined ocular hypertensive response to dexametha-
sone ointment applied to the eyelids in children after 
epiblepharon surgery. 
Materials and Methods
A total of 96 patients (50 boys, 46 girls) who underwent 
epiblepharon surgery at 2 hospitals between 2003 and 2005 
were recruited and prospectively evaluated. The parents of 
the patients were informed that their children would need YJ  Lee,  et  al.  STEROID  RESPONSE  IN  CHILDREN
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Armaly
9 Biender  et  al.
11 Lam  et  al.
14
Present  study
Group  A*  Group  B
†
Age  (years)
Mean
Range
Adult
(16-40)
9.7
(4-19)
6.5
(3-10)
6.49±2.7
(3-16)
Frequency  of  administration
(time/day)
34   4   4 2 - 3
Duration  of  administration
(weeks)
46   4   2 3  
Sample  size 80 44   132  142 96
Low  responder
(ΔIOP  <6  mmHg)
53  (66%) 39  (89%) (21.2%)  (26.8%) 34  (35.4%)
Intermediate  responder
(ΔIOP  6-15  mmHg)
23  (29%) 4  (9%) (45.5%)  (54.9%) 54  (56.3%)
High  responder
(ΔIOP  >15  mmHg)
4  (5%) 1  (2%) (33.3%)  (18.3%) 8  (8.3%)
*:  duration  of  steroid  treatment  was  4  weeks. 
†:  duration  of  steroid  treatment  was  2  weeks.
Table 2. Comparison  of  ocular-hypertensive  response  to  topical  dexamethas o n e  0 . 1 %  i n  d i f f e r e n t  s t u d i e s  
steroid ointment to reduce inflammation of the surgical 
wound which may have a possibility of increasing IOP. Only 
those patients whose parents provided informed consent were 
included in the study. Patients who had a preoperative IOP 
of 21 mmHg or more were excluded. Those who had a 
family history of glaucoma or did not comply with the serial 
IOP measurement were excluded from the study. 
Epiblepharon surgery was performed by 2 surgeons (YJL 
or KIW) under general anesthesia using the same surgical 
method.1 Making a skin incision below the lash line, the 
redundant skin and abundant orbicularis muscle were excised 
and 3-6 buried rotating sutures between the subcutaneous 
tissue of the upper skin flap and the tarsal plate were made. 
The wound was closed continuously with 6-0 fast absorbing 
gut suture.
After the surgery, the parents of the patients were 
instructed to apply dexamethasone-neomycin-polymyxin oint-
ment (Dexcosil
Ⓡ, Young Jin Pharm.) only to the surgical 
wound and not into the eye from the postoperative day 1 to 
the third week. They used the ointment 3 times a day for the 
first postoperative week and twice a day up until the third 
week.
IOP was evaluated on the day before the operation and on 
postoperative days 1, 7, 14, 21 and 28. It was measured by 
non-contact tonometry and Goldmann applanation tonometry 
for a confirmation test in those cases with an IOP higher than 
20 mmHg. Non contact tonometry was used because of its 
acceptability in children and previous reports validating its 
reliability.
9,10 Therefore, analysis of results in the present 
study was based on the reading of noncontact tonometry. 
Three consistent readings were obtained from each eye and 
the mean value was use for analysis. Dexamethasone oint-
ment was discontinued immediately in any eyes with an IOP 
higher than 25 mmHg and measurement was continued at 
1-week intervals until IOP measurements returned to the 
preoperative levels. Antiglaucoma medication would be 
started when the IOP did not decrease during next follow-up 
visit and sustained increased level. Peak IOP was defined as 
the highest IOP during follow-up period.
The demographic data of the patients was calculated by 
descriptive statistics. The unpaired t-test was used to compare 
the difference in IOP changes between different age groups. 
A P-value of less than 0.05 was defined as statistically signif-
icant. 
Results
One hundred and ninety-two eyes of 96 children were 
included. There was a high correlation between the pre-
operative IOP in the right eye and left eyes of subjects (p= 
0.087). Therefore the results of the right eye were used for 
analysis. The mean age of the 96 children (50 boys, 46 girls) 
was 6.5±2.7 years (range, 3-13 years). All the operations 
were uneventful and there were no postoperative compli-
cations. 
The mean preoperative IOP of the patients was 13.6±2.9
Measure Mean±SD  (range)
Preoperative  IOP  (mmHg)
Peak  IOP  (mmHg)
Delta  IOP  (mmHg)
Mean  time  to  reach  peak  IOP  (days)
13.6±2.9  (7-19)  
20.6±4.9  (11-39)
 7 . 2 ±5.4  (0-31)
 8 . 5 ±5.9  (1-28)
Table 1. Intraocular  pressure  (IOP)  profile  and  time  to 
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Measure ≤5  years >5 P  value*
Peak  IOP  (mmHg)
Delta  IOP  (mmHg)
Time  to  reach  peak  IOP  (days)
22.5±6.4
 9 . 4 ±7.5
 7 . 9 ±5.8
19.7±4.3
 6 . 3 ±4.4
10.0±6.2
0.020
0.015
0.120
*unpaired  t-test. 
Table 3. Comparison  of  ocular-  hypertensive  response  to  dexamethasone  ointment  in  different  age  groups
mmHg (range 7-19 mmHg). The peak IOP after the surgery 
was 20.6±4.9 mmHg (range 11-39 mmHg). Delta IOP 
(between the peak IOP and preoperative IOP) was 7.2±5.4 
mmHg (range 0-31 mmHg). After dexamethasone treatment 
there was a significant increase in IOP (paired t-test, 
P=0.000) (Table 1). 
The mean time to peak IOP was 8.5±5.9 days (range 
from 1 to 28 days). After dexamethasone ointment treatment, 
the cumulative percentage of eyes having IOP higher than 20 
mmHg at days, 1, 7, 14, 21, 28 were 1.0, 29.2, 35.4, 36.5 
and 50% respectively. The number of patients with an IOP 
higher than 20 mmHg in our study was 48 (50%). Any 
patients with an IOP more than 25 mmHg did not continue 
steroid treatment and the patients were checked by 1-week 
interval follow-up until their IOP returned to the preoperative 
level. After withdrawl of steroid treatment, all the elevated 
IOP had begun to decrease at the next follow-up. Any 
patients with an increased IOP did not complain of ocular 
hypertensive symptom, for example headache, blurring, 
ocular pain, etc. The one patient with an increased IOP of 
39 mmHg was checked by 3-day interval until his IOP was 
returned to preoperative level. We examined his optic disc, 
visual acuity which had not changed during increasing IOP, 
but we could not examine his visual fields because he was 
too young. His IOP returned to the preoperative level in 6 
days and kept the same level until 3 months postoperatively. 
Any patients with an increased IOP did not need antiglau-
coma medication to reduce their increased IOP.
According to Armaly’s classification,
11 35.4% (34/96) of 
patients in our group were low responders (delta IOP ≤5 
mmHg), 56.3% (54/96) were intermediate responders (delta 
IOP 6-15 mmHg), and 8.3% (8/96) were high responders 
(delta IOP ≥16). Children 5 years old or less had a higher 
peak IOP (22.5±6.4 mmHg) compared to that of children 
older than 5 years (19.7±4.3 mmHg, P=0.020). In addition, 
the delta IOP was higher in children 5 years old or less (age 
≤5 years, 9.4±7.5 mmHg vs. age >5 years, 6.3±4.4 
mmHg; P=0.015). The time to peak IOP was not different 
in the 2 groups (age ≤5 years, 7.9±5.8 days vs age >5 
years, 10.0±6.2 days; P=0.120) (Table 3).
Discussion
Steroid-induced ocular hypertension is a well documented 
entity in adults. The response of IOP to topical corticosteroid 
treatment had been demonstrated by Armaly
9 after subjecting 
a segment of the normal population to topical corticosteroid 
application and monitoring the increase in their IOP. How-
ever, in children, there has been limited information.
12 Most 
clinicians treat pediatric patients based on adult results but 
there is controversy in reported steroid response in children. 
Biender et al.
13 has reported an ocular hypertensive response 
to topical corticosteroid therapy in children with vernal 
keratoconjunctivitis (n=44, 4-19 years of age). They showed 
that response to steroids is not significantly different between 
adults and children. 
In contrast, Ohji et al.
14 reported that of 11 children (82%) 
were high or intermediate steroid responders after adminis-
tration of topical 0.1% dexamethasone eyedrops for 4 weeks 
following squint surgery. Kwok et al.
15 reported that ocular 
hypertensive response to topical dexamethasone in children 
occurs more frequently, more severely and more rapidly than 
reported in adults and demonstrated that 56% of the children 
in the study were high responders. Recently, Lam et al.
16 
studied the use of topical dexamethasone 0.1% in 2 different 
postoperative regimens (4 times vs. twice daily regimen for 
a 4-week course) after squint surgery and reported that ocular 
hypertensive response in children was as dose-dependent as 
age-dependent. Now there is growing evidence that ocular 
hypertensive response in children is more severe in relation 
to peak IOP, time to peak IOP and dosage of steroids used. 
Unitl now, Armaly’s classification has been used the most 
popularly and cited in many different studies.
13-17 Armaly
9 in 
1965 reported that only 5% of adult patients in the study 
were high responders (increase in IOP greater than 15 
mmHg) and 35% were intermediate responders (increase in 
IOP between 6 and 15 mmHg). They also reported that IOP 
increases more frequently in people aged 40 years or more 
than in people aged 18-30 years after instillation of 0.1% 
dexamethasone eyedrops. In our study, low, intermediate and 
high responders were 35.4% (34/96), 56.3% (54/96), and 
8.3% (8/96) respectively. 
The proportion of low and intermediate responders in our 
result were different with Armaly’s result, but there was some 
limitation in comparing our results directly with Armaly’s
11 
results because there was other variables, for example, opera-
tion, frequency of administration, kind of drug. Comparing 
our results with other different studies on children was 
summarized in Table 2. Although taking variables into 
consideration, high responders in children in our study is 
lower than in Lam et al.
14 and more than Armaly’s and 
Biender et al.
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In comparison to Lam et al.
16, the high responders in our 
study (8%) were fewer than in Lam et al’s (33.3%). It was 
supposed that they used topical dexamethasone for longer 
period (4 weeks) and more frequently (4 times) than we did. 
It is well established that the amount of increase in IOP 
depends on numerous factors such as drug potency, penetra-
tion, dosage and length of administration. Ng et al.
17 demon-
strated a dose-dependent ocular hypertensive response to 
topical dexamethasone in children. They showed the 4 times 
daily group had a significantly higher peak as well as a 
higher net increase in IOP than the twice daily group. More-
over steroid eyedrops which were used in many other reports 
acted directly on the eye. In contrast, we used ointment 
which had a different penetration in comparison with eye-
drops. It was not clear how the steroid ointment could evoke 
ocular hypertensive response, but it was assumed that it could 
be related to the systemic absorption of corticosteroid through 
the skin of the eyelid, especially when there was a surgical 
wound.
18 Alternatively, a sufficient amount of ointment could 
have seeped over the eyelid margins to cause the rise in IOP 
similar to the application of corticosteroid eyedrops. Chua et 
al.,
19 reported a similar case of accelerated ocular hypertensive 
response after application of corticosteroid ointment to a 
6-year-old boy’s eyelid after leveator palpebrae superioris 
resection. His IOP was elevated to 44 mmHg at 4 days 
postoperative. This was an alarming case because in children, 
the ocular hypertensive response may be severe and rapid 
even with the corticosteroid ointment applied only to the 
eyelid. 
The response to corticosteroids in children has been 
explained by functional immaturity of the trabecular mesh-
work, which is unable to respond to this accumulation of 
glycosaminoglycans resulting in an increased resistance to 
aqueous outflow.
20-22 This age-dependent response was also 
demonstrated in rabbits and was supported by the difference 
in distribution and structure of proteoglycans. Remé and d’ 
Epiney
23 reported that chamber angle structures were imma-
ture at birth. Although fully present at birth, it takes 
approximately 8 years for the whole chamber angle to 
become as mature as that of an adult. Knepper et al.
24 
showed age-dependent steroid-induced glaucoma in a rabbit 
model. The young rabbits were steroid responders, whereas, 
none of the older rabbits showed any IOP rise. Lam et al.
16 
found that children aged 6 years or younger had a higher 
peak IOP and a net increase in IOP as compared with 
children older than 6 years when topical dexamethasone was 
used 4 times daily. In our study, children less than 5 years 
old had a higher peak IOP (22.5±6.4 mmHg) as compared 
to that of children older than 5 years (19.8±4.3 mmHg; p 
=0.020). 
Discontinuation of steroid use is the first line of defense 
and is often all that is required.
25 Increased IOP returned to 
preoperative levels in all patients in our study after cessation 
of ointment. There was no persistent IOP elevation after a 
week. There are 2 forms of normalization in increased IOP 
in steroid induced ocular hypertension. In the chronic form, 
the increased IOP becomes normalized in 1-4 weeks, whereas 
the acute form typically resolves within days of stopping the 
steroid. The duration of steroid therapy appears to influence 
the reversibility of the IOP elevation. Because steroid oint-
ment was used for a short period in this study, all of the 
patients showed the acute form of ocular hypertension.
In conclusion, our study was performed on patients who 
underwent epiblepharon surgery, which is commonly per-
formed in Asians and showed that use of steroid ointment to 
the operated eyelids in children might cause a more severe 
ocular hypertensive response than in adults. In the future 
study, it is suggested to design the adults and children group 
treated with the same operation and the same management 
and follow-up. Also it needs further investigation why the 
children with highly elevated IOP did not complain of any 
symptoms. 
Topical dexamethasone ointment should be used carefully 
in children because exaggerated ocular hypertensive response 
occurs frequently. It is essential to monitor IOP when corti-
costeroid ointment is used on the eyelids of young children.
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